Rutherford Diagnostics and Philips agree 10 year partnership to improve diagnostic services and patient outcomes across Engla...
14 Maggio 2019 - 9:59AM
Rutherford Diagnostics and Philips agree 10 year partnership to
improve diagnostic services and patient outcomes across England
May 14, 2019
- Partnership to utilize innovative technology to increase access
to diagnostic services with five new community sites across
England
- Agreement aims to deliver first class, patient-centered
diagnostic services
Amsterdam, the Netherlands and Guildford, the
UK – Royal Philips (NYSE: PHG, AEX: PHIA) a leading global
health technology company, has announced it signed a 10-year
strategic partnership agreement with Rutherford Diagnostics. This
collaboration will utilize Philips innovative radiology technology
and Rutherford Diagnostics’ healthcare expertise to deliver and
operate advanced personalized diagnostic services through a network
of community diagnostic centers, driving the best possible
healthcare outcomes for patients. Rutherford Diagnostics is a
subsidiary of Proton Partners International which operates
diagnostic and cancer centers across the United Kingdom.
The agreement has a term of 10-years and the two organizations
will work in partnership to deliver advanced diagnostics services,
through five new diagnostics centers across the UK. Under the terms
of the agreement, which is built around a Managed Technology
Service, Philips will deliver: state-of-the-art imaging equipment
provision; management and technology utilization reporting;
continuous training; and a research and innovation program.
"For Philips, a successful managed service uses technology as an
enabler to drive improved clinical practices and patient outcomes
through innovation and sustainability,” said Stephen McMillan,
Solutions Lead for Philips in the UK. “We believe this partnership
with Rutherford Diagnostics is an opportunity to deliver a truly
patient-centric diagnostic service with high levels of staff
satisfaction. Philips already has a number of innovative managed
service agreements with NHS partners here in the UK, so this is an
exciting expansion of this service for us, as we partner with our
first private provider.”
Philips and Rutherford Diagnostics will help expand access to
diagnostic services for local patients in a cost-effective way that
supports the best possible patient outcomes and experiences.
“Our focus is to change the current healthcare paradigm from a
reactive model which responds to disease, to one that is proactive
and preventative with far reaching long-term benefits,” said Dr
Steven Powell, Chief Executive Officer of Rutherford Diagnostics.
“We required a strategic partner who will complement our diagnostic
service offering with technological innovation. Philips is closely
aligned to our vision and can manage complexity while remaining
flexible and is the right partner to support us on this
journey.”
The first three community diagnostic centers are due to go live
in 2020, with the remaining two in 2021. The first site is expected
to welcome patients in Liverpool in 2020.
For further information, please contact: Joost
MalthaPhilips Group Press OfficeTel. +31 6 10 55 8116E-mail:
joost.maltha@philips.com
Jonathan FalconePhilips United Kingdom & Ireland Tel. +44
(0)7789 925 134E-mail: jonathan.falcone@philips.com
About Royal PhilipsAbout Royal
Philips Royal Philips (NYSE: PHG, AEX: PHIA) is a leading health
technology company focused on improving people's health and
enabling better outcomes across the health continuum from healthy
living and prevention, to diagnosis, treatment and home care.
Philips leverages advanced technology and deep clinical and
consumer insights to deliver integrated solutions. Headquartered in
the Netherlands, the company is a leader in diagnostic imaging,
image-guided therapy, patient monitoring and health informatics, as
well as in consumer health and home care. Philips generated 2018
sales of EUR 18.1 billion and employs approximately 77,000
employees with sales and services in more than 100 countries. News
about Philips can be found at www.philips.com/newscenter.
About Rutherford
DiagnosticsTransforming Medical Diagnostics – a
progressive approach for a better futureRutherford
Diagnostics was established to fulfil a much-needed requirement for
more advanced diagnostics services. We are developing a
network of diagnostics centres across the UK to instigate change
from the current reactive paradigm which often results in late
stage diagnosis - to a proactive paradigm of prediction, prevention
and earliest possible detection of disease. Our philosophy is
to strive for world class quality care and we believe getting the
basics of care right every time means the right diagnosis first
time to ensure the best outcomes. By providing state of the art
facilities and advanced clinical equipment we offer the highest
level of efficiency and diagnostic yield, we can offer safe and
clinically effective services with compassion and sensitivity for
outstanding patient experience.
Grafico Azioni Koninklijke Philips NV (EU:PHIA)
Storico
Da Mar 2024 a Apr 2024
Grafico Azioni Koninklijke Philips NV (EU:PHIA)
Storico
Da Apr 2023 a Apr 2024
